关键词

Transcatheter treatment; cardiac valvular diseases; minimally invasive; outcomes; patient selection; procedural techniques; long-term durability; post-procedural management; research prospects; technological advancements

全文

PDF

参考

[1] Nishimura, R. A., Otto, C. M., Bonow, R. O., et al. (2017). 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the
management of patients with valvular heart disease: A Report of the American College of Cardiology/American Heart Association Task Force
on Clinical Practice Guidelines. Circulation, 135(25), e1159-e1195.
[2] Iung, B., & Vahanian, A. (2011). Epidemiology of valvular heart disease in the adult. Nature Reviews Cardiology, 8(3), 162-172.
[3] Carabello, B. A., & Paulus, W. J. (2009). Aortic stenosis. The Lancet, 373(9667), 956-966.
[4] Nkomo, V. T., Gardin, J. M., Skelton, T. N., et al. (2006). Burden of valvular heart diseases: A population-based study. The Lancet,
368(9540), 1005-1011.
[5] Reardon, M. J., Adams, D. H., Kleiman, N. S., et al. (2015). 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding
Transcatheter Aortic Valve Replacement. Journal of the American College of Cardiology, 66(2), 113-121.
[6] Webb, J. G., Pasupati, S., Achtem, L., et al. (2007). Percutaneous transarterial aortic valve replacement in selected high-risk patients with
aortic stenosis. Circulation, 116(7), 755-763.
[7] Herrmann, H. C., Thourani, V. H., Kodali, S. K., et al. (2019). One-Year Outcomes With Transcatheter Valve-in-Valve Repair Versus
Sutured Surgical Bioprosthetic Valve Replacement: The PARTNER 2 Registry. Journal of the American College of Cardiology, 73(22), 2833-2842.
[8] Kodali, S. K., Velagapudi, P., & Hahn, R. T. (2020). Transcatheter aortic valve replacement for aortic stenosis: current and future
perspectives. JACC: Cardiovascular Interventions, 13(6), 715-732.
[9] Stone, G. W., & Mack, M. J. (2019). Transcatheter aortic valve replacement: new standards, more patients. Cardiovascular Research,
115(3), e14-e17.
[10] O'Gara, P. T., Grayburn, P. A., Badhwar, V., et al. (2017). 2017 ACC expert consensus decision pathway on the management of mitral
regurgitation: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. Journal of the American
College of Cardiology, 70(19), 2421-2449.
[11] Popma, J. J., Deeb, G. M., Yakubov, S. J., et al. (2019). Transcatheter aortic-valve replacement with a self-expanding valve in low-risk
patients. New England Journal of Medicine, 380(18), 1706-1715.
[12] Ailawadi, G., Lim, D. S., Mack, M. J., et al. (2021). One-year outcomes of transcatheter mitral valve replacement in patients with severe
mitral annular calcification. JAMA Cardiology, 6(8), 915-925.
[13] Barbanti, M., Webb, J. G., Hahn, R. T., et al. (2013). Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome
after transcatheter and surgical aortic valve replacement: Insight from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial
cohort A. Circulation, 128(24), 2776-2784.
[14] Leon, M. B., Smith, C. R., Mack, M. J., et al. (2016). Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.
New England Journal of Medicine, 374(17), 1609-1620.